Mediland Pharm Limited announced audited consolidated earnings results for the full year ended June 30, 2020. For the full year, the company announced sales was AUD 23,298,447 compared to AUD 30,661,259 a year ago. Loss after income tax expense for the year attributable to the owners of Mediland Pharm Limited was AUD 5,109,041 compared to AUD 11,244 a year ago. Basic loss per share was 1.63 cents compared to 0.01 cents a year ago.